APOBEC3B and breast carcinoma: Thus, APOBEC3B is a marker of poor prognosis for ER+ breast cancer, which strongly suggests that genetic aberrations induced by APOBEC3B contribute to breast cancer progression or resistance to treatment [10, 11].